major depressive disorder Archives - Express Pharma

Strides gets USFDA approval for Fluoxetine Tabs 10 mg and 20 mg

Suven announces randomisation of first patient in Phase-2 POC clinical trial of Ropanicant (SUVN-911)

MDD market across 8MM to reach $9.6 bn by 2029 driven by novel drug launches: GlobalData

FDA accepts NDA and grants priority review of Zuranolone from Sage Therapeutics, Biogen

Novel pipeline agents to drive global major depressive disorder market: GlobalData

US FDA approves SPRAVATO, antidepressant medication from J&J

FDA approves new drug Rexulti to treat schizophrenia

Suven secures one product patent each in Mexico and Singapore

Suven Life secures product patents from Australia, Hong Kong and Japan